Search -

Displaying 361 - 380 of 416

Sort: Relevancy | Date

News Conference News ESC 2015

NSAIDs Plus Anticoagulants a Bad Combination

Caitlin E. Cox

September 01, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market

May 28, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

News Daily News

Periprocedural Acute Kidney Injury Linked to Increased Mortality in PAD Patients

January 28, 2015

News Daily News

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

January 28, 2015

News Daily News

Catheter-Based Measurement of Plaque Lipid Predicts Future Events

December 10, 2014

News Daily News

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

November 17, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

September 14, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Industry News

BIOTRONIK Announces Completion of Enrollment in SFA Arm of the BIOFLEX-I Study

July 22, 2014

News Industry News

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

June 05, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Daily News

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

April 21, 2014

News Daily News

ZES Continue to Match EES in All Comers at 4 Years

March 13, 2014

News Daily News

Fever After TAVR Common, but Antibiotics Rarely Needed

L.A. McKeown

January 15, 2014

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

Advertisement

NSAIDs Plus Anticoagulants a Bad Combination

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Periprocedural Acute Kidney Injury Linked to Increased Mortality in PAD Patients

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

Catheter-Based Measurement of Plaque Lipid Predicts Future Events

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

BIOTRONIK Announces Completion of Enrollment in SFA Arm of the BIOFLEX-I Study

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

ZES Continue to Match EES in All Comers at 4 Years

Fever After TAVR Common, but Antibiotics Rarely Needed

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content